|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Revivicor
|
|
gptkbp:awards
|
Best Places to Work
Fastest Growing Companies
Top 100 Best Workplaces
|
|
gptkbp:ceo
|
gptkb:Martine_Rothblatt
|
|
gptkbp:clinical_trial
|
Phase 3 trials
Phase 1 trials
Phase 2 trials
|
|
gptkbp:collaborations
|
gptkb:NHLBI
gptkb:NIAID
gptkb:NIMH
gptkb:FDA
gptkb:NINDS
|
|
gptkbp:employees
|
over 500
|
|
gptkbp:focus
|
organ transplantation
pulmonary arterial hypertension
|
|
gptkbp:founded
|
gptkb:1996
|
|
gptkbp:founder
|
gptkb:Martine_Rothblatt
|
|
gptkbp:headcount
|
approximately 600
|
|
gptkbp:headquarters
|
gptkb:Silver_Spring,_Maryland
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
United Therapeutics Corporation
|
|
gptkbp:industry
|
gptkb:drug
|
|
gptkbp:location
|
gptkb:Europe
gptkb:Asia
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:partnership
|
United Therapeutics and the University of Maryland
|
|
gptkbp:products
|
gptkb:Orenitram
gptkb:Remodulin
gptkb:Tyvaso
gptkb:Unituxin
|
|
gptkbp:research
|
gptkb:physicist
gptkb:Company
xenotransplantation
|
|
gptkbp:subsidiary
|
gptkb:Revivicor
gptkb:United_Therapeutics_Corporation_of_Canada
|
|
gptkbp:symbol
|
UTHR
|
|
gptkbp:website
|
www.unither.com
|
|
gptkbp:bfsParent
|
gptkb:Mann_Kind_Corporation
|
|
gptkbp:bfsLayer
|
5
|